Antivertigo agents. III. Synthesis of 5,6,7,8-tetrahydro-1,6-naphthyridine methyl homologs

DOI: 10.1248/cpb.32.2522

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2522 - 2529 (1984)

Update date:2022-08-04

Topics:

Authors:

Shiozawa

Ichikawa

Komuro Komuro

Kurashige

Miyazaki

Yamanaka

Sakamoto

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.32.2522

Full text of DOI:10.1248/cpb.32.2522

NII-Electronic Library Service

Products guided by the article

Product name:1,6-Naphthyridine, 5,6-dihydro-5-methyl-6-(phenylmethyl)-

Cas No:83081-98-5

R&D Labs maybe for 83081-98-5

WUHAN WELLSONG INT'L CO.,LTD

Contact:+86-27-85733560

Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
Shanghai WinTide BioTechnology Co.,Ltd

Contact:86-21-37100630

Address:No. 908 Yunhe Road, Fengxian district, Shanghai
shijiazhuang baisheng chem co.; ltd

Contact:86-0311-80790826

Address:shijiazhuang hebei
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD

Contact:+86-25-86883560 15951806178

Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
Laizhou City Laiyu Chemical CO.,Ltd

Contact:+86-535-2719337/2719339

Address:Chenggang road zhuyou laizhou City Shangdong China

Relevant to this article

Doi:10.1021/ja01134a039
(1952)
5-(Haloalkyl)-2'-deoxyuridines: A Novel Type of Potent Antiviral Nucleoside Analogue

Doi:10.1021/jm00149a024
(1985)
Thermal Rearrangement of Benzisoxazole- and Naphthisoxazolequinones in Solution and in the Solid State. Stereoselective Synthesis of γ-Cyanomethylidenebutenolides.

Doi:10.1016/S0040-4020(01)80370-7
(1993)
Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: Characterization of α- amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D- aspartate) receptor and anticonvulsant activ

Doi:10.1021/jm00019a003
(1995)
A Formal Total Asymmetric Synthesis of (+)-Thienamycin

Doi:10.1016/0957-4166(95)00327-L
(1995)
Synthesis and deprotection of β-silylethyl protected O,O,O-and O,O,S-trialkylphosphorothioates

Doi:10.1016/0040-4039(96)00228-6
(1996)

Article Doi